Literature DB >> 3094839

Role of ornithine decarboxylase and the polyamines in nervous system development: a review.

T A Slotkin, J Bartolome.   

Abstract

Development of nervous tissue is controlled, in part, by the ornithine decarboxylase (ODC)/polyamine system. Each brain region possesses a unique ontogenetic pattern for ODC, with highest levels of the enzyme associated with periods of most rapid growth. For this reason, perturbation of the ODC profile has proven useful in examinations of teratologic mechanisms and detection of adverse environmental effects during development. More recently, the replication of neuronal cells in developing brain has been shown to require the maintenance of polyamine levels and consequently, depletion of polyamines by alpha-difluoromethylornithine (DFMO, an ODC inhibitor) arrests brain cell maturation. DFMO also interferes with neuronal migration, axonogenesis and synaptogenesis, leading to disruption of the cytoarchitectural organization of brain structures: these results imply a similarly important role for polyamines in post-replicative events. Indeed, [3H]DFMO-autoradiographic localization of ODC in developing cerebellar lamina indicates high levels of activity associated with neuropil, areas of axonal outgrowth, and post-mitotic granule cells. Axonal outgrowth during regeneration after nerve damage in the mature nervous system may display some of the same characteristics as in developing neurons, suggesting that the two processes share common polyamine-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094839     DOI: 10.1016/0361-9230(86)90236-4

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  25 in total

Review 1.  A role for cAMP in regeneration of the adult mammalian CNS.

Authors:  Tim Spencer; Marie T Filbin
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

2.  Spermine binding to Parkinson's protein alpha-synuclein and its disease-related A30P and A53T mutants.

Authors:  Megan Grabenauer; Summer L Bernstein; Jennifer C Lee; Thomas Wyttenbach; Nicholas F Dupuis; Harry B Gray; Jay R Winkler; Michael T Bowers
Journal:  J Phys Chem B       Date:  2008-08-09       Impact factor: 2.991

3.  Effect of histamine on the development of astroglial cells in culture.

Authors:  J Rodriguez; J Moran; I Blanco; A J Patel
Journal:  Neurochem Res       Date:  1989-07       Impact factor: 3.996

4.  Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure.

Authors:  B Lewis; K A Wellmann; S Barron
Journal:  Pharmacol Biochem Behav       Date:  2007-07-25       Impact factor: 3.533

5.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

6.  Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules.

Authors:  Yuyu Song; Laura L Kirkpatrick; Alexander B Schilling; Donald L Helseth; Nicolas Chabot; Jeffrey W Keillor; Gail V W Johnson; Scott T Brady
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

7.  Difluoromethylornithine (DFMO) reduces deficits in isolation-induced ultrasonic vocalizations and balance following neonatal ethanol exposure in rats.

Authors:  Maribel A Rubin; Kristen A Wellmann; Ben Lewis; Ben J Overgaauw; John M Littleton; Susan Barron
Journal:  Pharmacol Biochem Behav       Date:  2008-10-25       Impact factor: 3.533

8.  Agmatine reduces ultrasonic vocalization deficits in female rat pups exposed neonatally to ethanol.

Authors:  Kristen Wellmann; Ben Lewis; Susan Barron
Journal:  Neurotoxicol Teratol       Date:  2009-11-27       Impact factor: 3.763

Review 9.  Endogenous ornithine in search for CNS functions and therapeutic applications.

Authors:  N Seiler; G Daune-Anglard
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

10.  Polyamine metabolism in gliomas.

Authors:  R I Ernestus; G Röhn; R Schröder; T Els; J Y Lee; N Klug; W Paschen
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.